Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 198

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 198
---
 in the issuance costs of the February 2023 Public Offering and treated as a liability (see Note 10). From March 13, 2023 to December 31, 2024, the Company received notices of alternative cashless exercises for 6,217,640Class C Common Stock Warrants issued in connection with the February 2023 Public Offering for 5,160shares of common stock. As of December 31, 2024, there were 232,360of Class C Common Stock Warrants outstanding to purchase up to 485shares of common stock. As part of the Class D Warrant Inducement (defined below) on August 22, 2024, the exercise price of the Class C Common Stock Warrants was reset from $ 38.24to $ 16.00. 6. 2024 Public Offering On February 5, 2024, the Company closed a public offering of 8,029shares of its common stock, 77,282pre-funded warrants to purchase shares of common stock with an exercise price of $ 0.0016which did not have an expiration date (the “Class D Pre-Funded Warrants”) and 2,730,000warrants to purchase up to 170,628shares of common stock with an exercise price of $ 72.48which expire on February 5, 2029(the “Class D Common Stock Warrants”) at a combined offering price of $ 72.48per share of common stock and two Class D Common Stock Warrants, or $ 72.4784per Class C Pre-Funded Warrant and two Class D Common Stock Warrants (the “February 2024 Public Offering”). Net cash proceeds to the Company from the offering were $ 5.4million and issuance costs were $ 0.8million. F-13 REVELATION BIOSCIENCES, INC.
Notes to the Consolidated Financial Statements 6. 2024 Public Offering(cont.) Roth was engaged by the Company to act as its exclusive placement agent for the February 2024 Public Offering. The Company paid Roth a cash fee equal to 8.0% of the gross proceeds received by the Company in the public offering, totaling $ 0.5million of issuance costs. The shares of common stock underlying the Class D Pre-Funded Warrants and the shares of common stock underlying the Class D Common Stock Warrants were registered with the SEC on Form S-1 (File No. 333